Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2026-02-25 @ 6:43 PM
Study NCT ID:
NCT00546156
Status:
COMPLETED
Last Update Posted:
2021-05-18
First Post:
2007-10-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer
Sponsor:
Ian E. Krop, MD, PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10
Start Date Type:
None
Primary Completion Date:
2011-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-17
First Submit QC Date:
None
Study First Post Date:
2007-10-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-03-22
Results First Submit QC Date:
None
Results First Post Date:
2013-05-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-26
Last Update Post Date:
2021-05-18
Last Update Post Date Type:
ACTUAL